Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-07-02 00:00:00 ET · period of report 2024-07-01 · accession 0001493152-24-026088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | 2024-07-01 | BIAF | KNIGHT PETER S | Dir | A - Grant | $0.00 | +33.8K | 117.5K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | A | A | 33,784 | $0.00 | 117,455 | D | — | — | (F1) Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024. |